Diabete mellito e difetti ossei: una nuova strategia terapeutica (Anupgarh)

Diabete mellito e difetti ossei: una nuova strategia terapeutica (Anupgarh)

06 Aug
|
SIOMMMS Società Italiana dell’Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
|
Anupgarh

06 Aug

SIOMMMS Società Italiana dell’Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro

Anupgarh

Commento dell’articolo: Ferrari S, Hars M, Biver E, Uebelhart B, Joly AC, Herrmann F, Meier C, Lippuner K. Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates....

📌 Diabete mellito e difetti ossei: una nuova strategia terapeutica (Anupgarh)
🏢 SIOMMMS Società Italiana dell’Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
📍 Anupgarh

Reply to this offer

Impress this employer describing Your skills and abilities, fill out the form below and leave Your personal touch in the presentation letter.

Subscribe to this job alert:

Get the latest job offers by email for: diabete mellito e difetti ossei: una nuova strategia terapeutica (anupgarh) / anupgarh

Subscribe to this job alert:

Get the latest job offers by email for: diabete mellito e difetti ossei: una nuova strategia terapeutica (anupgarh) / anupgarh